An Alzheimer's pill appears to protect some in a high-risk population
Summary
A drug called ALZ-801 might protect people at high risk of Alzheimer's, especially those with mild memory issues. It showed promise in slowing brain changes linked to Alzheimer's. The drug is easy to take as a pill, unlike some existing treatments that require infusions.Key Facts
- ALZ-801 is an experimental drug being tested for Alzheimer's.
- Initial tests showed no clear benefit over a placebo for most patients.
- A subgroup of patients with mild memory issues showed a 52% slower decline in cognitive abilities.
- ALZ-801 reduced brain shrinkage in the hippocampus by 18%, an area important for memory.
- The drug is supported by a $47 million NIH grant.
- ALZ-801 is a pill, making it easier to use than infusion-based treatments.
- Existing treatments targeting amyloid plaques can cause side effects like brain swelling, but ALZ-801 does not.
- People with the APOE4 gene, linked to higher Alzheimer's risk, might benefit from the gentler effects of ALZ-801.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.